Literature DB >> 10419556

Inhibition of protein kinases by balanol: specificity within the serine/threonine protein kinase subfamily.

J Setyawan1, K Koide, T C Diller, M E Bunnage, S S Taylor, K C Nicolaou, L L Brunton.   

Abstract

Balanol is a potent inhibitor of cyclic AMP-dependent protein kinase and protein kinase C, acting competitively with ATP with an affinity 3000 times that of ATP. We tested the capacity of balanol to inhibit representative serine- and threonine-specific protein kinases from the protein kinase subfamily that shares a common conserved catalytic core with cyclic AMP-dependent protein kinase. Balanol's pattern of interactions indicates considerable diversity of the ATP/balanol-binding sites of protein kinases within familial groups and even among isoforms of the same kinase. We propose that balanol is a protean structure that may be modified to produce selective, high-affinity inhibitors and probes of the ATP-binding sites of serine/threonine protein kinases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419556     DOI: 10.1124/mol.56.2.370

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

Review 1.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

2.  Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors.

Authors:  David M Thal; Raymond Y Yeow; Christian Schoenau; Jochen Huber; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2011-05-19       Impact factor: 4.436

3.  Mechanistic characterization of the 5'-triphosphate-dependent activation of PKR: lack of 5'-end nucleobase specificity, evidence for a distinct triphosphate binding site, and a critical role for the dsRBD.

Authors:  Rebecca Toroney; Chelsea M Hull; Joshua E Sokoloski; Philip C Bevilacqua
Journal:  RNA       Date:  2012-08-21       Impact factor: 4.942

4.  Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol.

Authors:  John J G Tesmer; Valerie M Tesmer; David T Lodowski; Henning Steinhagen; Jochen Huber
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

5.  Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46.

Authors:  Liying Qin; Banumathi Sankaran; Sahar Aminzai; Darren E Casteel; Choel Kim
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

Review 6.  The essential roles of chemistry in high-throughput screening triage.

Authors:  Jayme L Dahlin; Michael A Walters
Journal:  Future Med Chem       Date:  2014-07       Impact factor: 3.808

7.  Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors.

Authors:  Helen V Waldschmidt; Kristoff T Homan; Osvaldo Cruz-Rodríguez; Marilyn C Cato; Jessica Waninger-Saroni; Kelly M Larimore; Alessandro Cannavo; Jianliang Song; Joseph Y Cheung; Paul D Kirchhoff; Walter J Koch; John J G Tesmer; Scott D Larsen
Journal:  J Med Chem       Date:  2016-04-13       Impact factor: 7.446

Review 8.  Molecular basis for small molecule inhibition of G protein-coupled receptor kinases.

Authors:  Kristoff T Homan; John J G Tesmer
Journal:  ACS Chem Biol       Date:  2014-07-14       Impact factor: 5.100

Review 9.  Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling.

Authors:  Supachoke Mangmool; Warisara Parichatikanond; Hitoshi Kurose
Journal:  Front Pharmacol       Date:  2018-11-27       Impact factor: 5.810

10.  Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility.

Authors:  David M Thal; Kristoff T Homan; Jun Chen; Emily K Wu; Patricia M Hinkle; Z Maggie Huang; J Kurt Chuprun; Jianliang Song; Erhe Gao; Joseph Y Cheung; Larry A Sklar; Walter J Koch; John J G Tesmer
Journal:  ACS Chem Biol       Date:  2012-08-21       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.